Condition
Non-rheumatic calcific aortic valve disease
Clinical trials and treatment information for Non-rheumatic calcific aortic valve disease
Treatment Rankings
Ranked by evidence volume first. Medicine has spent centuries ranking things by vibes. This is an improvement.
Comparative Safety Scale(Higher is safer)
Time to Effect
Immediate hemodynamic improvement, symptomatic relief within weeks to months post-recovery
Duration
One-time procedure; valve durability 10-20+ years; initial procedure cost $25,000-$50,000.
Response Rate
92%
Remission Rate
99%
Number Needed to Treat (NNT)
2
Common Side Effects:
Annual Cost of Care
Drug Cost
$0
Monitoring
$1,500
Side Effects
$1,200
Total Annual
$2,700
Cost-Effectiveness
GOODQALYs Gained
1.6
ICER
$70,000/QALY
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
Immediate hemodynamic improvement, symptomatic relief within days to weeks
Duration
One-time procedure; valve durability 10-15+ years; initial procedure cost $30,000-$60,000.
Response Rate
90%
Remission Rate
98%
Number Needed to Treat (NNT)
3
Common Side Effects:
Annual Cost of Care
Drug Cost
$0
Monitoring
$1,500
Side Effects
$1,000
Total Annual
$2,500
Cost-Effectiveness
GOODQALYs Gained
1.5
ICER
$80,000/QALY
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
Hours (for symptom relief)
Duration
Lifetime (as needed for symptoms)
Response Rate
70%
Remission Rate
0%
Common Side Effects:
Annual Cost of Care
Drug Cost
$100
Monitoring
$200
Side Effects
$100
Total Annual
$400
Cost-Effectiveness
EXCELLENTQALYs Gained
0.05
Cost per Responder
$571
Clinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
Long-term (for risk factor benefits), immediate (for watchful waiting assessment)
Duration
Lifetime (for monitoring and lifestyle)
Response Rate
%
Remission Rate
0%
Common Side Effects:
Annual Cost of Care
Drug Cost
$0
Monitoring
$500
Side Effects
$0
Total Annual
$500
Cost-Effectiveness
EXCELLENTClinical Trial Phases:
Comparative Safety Scale(Higher is safer)
Time to Effect
Not applicable (no effect on AS progression)
Duration
Lifetime (for lipid management)
Response Rate
0%
Remission Rate
0%
Common Side Effects:
Annual Cost of Care
Drug Cost
$50
Monitoring
$100
Side Effects
$50
Total Annual
$200
Cost-Effectiveness
EXCELLENTClinical Trial Phases: